Introduction
Numerous epidemiological studies have compared the body weights of smokers and non-smokers, and nearly all have found that smokers as a group weigh less than people who have never smoked.'-" Among men the inverse association between smoking and body weight is strongest in older smokers and weakest in younger smokers, which may be due to the duration of smoking.3 47 For example, metabolic studies have shown that smokers have an increased resting energy expenditure. 12 Behavioural, environmental, and cognitive factors, however, are also active determinants of diet, exercise, and body weight. To elucidate the reasons for the apparent reduction in weight difference between smokers and nonsmokers between the two survey years determinants of body weight among current smokers were first analysed cross sectionally. In the 1987 data age was a strong predictor of body weight among the younger smokers, but among the older smokers duration of smoking was the strongest. The number of cigarettes smoked a day was a significant positive predictor of body weight in younger but not older men (data not shown). When the analysis was repeated for the 1982 data the findings were practically identical. This showed that among the smokers smoking related predictors of body weight had not changed.
To estimate the importance of years of smoking as a predictor of body weight in men mean values of body mass index adjusted for age and number of cigarettes smoked daily were computed for men with histories of 1-10, 11-20, 21-30, 31-40, and ¢41 years of smoking (table III) . There was a consistent inverse gradient between years of smoking and relative weight that was especially pronounced after more than 20 years of smoking.
Among men smokers drank more alcohol, ate more saturated fats, exercised less, were less well educated, and had higher resting heart rates than non-smokers A further analysis of variance of body mass index in current male smokers in 1987 examined the interaction effect of alcohol consumption and age. Among the 25-44 year olds the highest average body mass index was found in those who were both heavy smokers and heavy drinkers, whereas in the older age group (45-64) men with high cigarette and alcohol consumption had the lowest body mass index. Owing to the comparatively small numbers of current smokers who reported some alcohol consumption during the week before the survey the three way interaction term failed to reach significance (p=0-10). The finding nevertheless illustrated the opposed character of the smokingalcohol-weight interrelation between younger men (synergistic) and older men (antagonistic) and indicated that the clustering of unhealthy habits tended to be more pronounced in younger than older middle aged men. Similar associations with body weight, alcohol consumption, and age were not seen in women smokers.
Discussion
Years of smoking have been shown to be the main determinant of lung cancer. Recently years of smoking has been recognised as the most informative measure of smoking for the risk of cardiovascular disease.23 It is also a predictor of body weight,7 and our cross sectional data accord with other observations of an inverse association between the duration of smoking and relative weight for men. Metabolic studies have shown an increased resting energy expenditure in smokers,'2 so it is not surprising that the cumulative negative effect of smoking on body weight should be most clearly seen after several years of smoking. An increased metabolic rate among smokers might also explain why smokers weigh less than non-smokers despite their sometimes higher energy intake and often lower levels of leisure activity.3424 On the other hand, the daily amount of smoking was a positive rather than negative predictor of body weight in younger smokers. Similar findings have been reported from The Netherlands.'
Our main finding was that the usually observed inverse association of smoking with body weight'-" disappeared in Finnish men and became substantially attenuated in Finnish women during 1982-7. Moreover, in as short a time as five years a substantial increase in weight had occurred both in smokers and in non-smokers. Interestingly, recently published figures from the United States also show that in two large population based surveys smokers were leaner than non-smokers in 1976-80 but no longer so in 1981-3.'°W e have little doubt that our observation was real. Weight and height of all subjects were measured by trained personnel under standardised conditions. Self reported smoking habits have been validated by measurement of serum thiocyanate concentration and shown to be reliable.'7 Alcohol consumption during the week before the survey was validated by measurement of serum y-glutamyltransferase activity,'8 and the appropriateness of the saturated fat intake variable, based on milk, butter, and margarine consumption, was tested with three day food consumption records.2'
What might be the reasons for a diminishing difference in body weight between smokers and nonsmokers in Finland? Other workers have also noted an intriguing modifying effect of age on the association between smoking history and body weight in cross sectional analyses.37 In a large representative sample of men and women from the United States current smokers aged up to 34 and with a history of smoking for 1-20 years were not leaner than age matched nonsmokers, whereas smokers aged 50 or over and with a history of smoking for less than 11 years were significantly leaner than non-smokers. index, which is also modified by differences in body build and muscularity.27 In general our results accord with observations from the United States of a clustering of negative health habits among smokers, which may have become more pronounced in recent years.8 We can only speculate why the characteristics of smokers in Finland seem to be changing. In the past smoking was considered to be a "normal" habit; but with the Finnish antismoking legislation from 1977, increased antismoking education, and changing public attitudes smoking is being regarded more as a deviant behaviour. Thus today smokers may be personalities more prone to risk taking and unhealthy behaviours than earlier. It may be hypothesised that the hard core of current smokers, who hitherto have resisted antismoking campaigns, consist of an increasing selection of people with unfavourable health behaviour. In another Finnish study28 persistence in smoking was associated with greater use of alcohol and coffee, possibly due to a common pathophysiology of dependence. 29 On the other hand, the average number of cigarettes smoked daily by current smokers did not increase from 1982 to 1987 as one would expect for the hypothesis of an increasing cluster of negative health habits.
In conclusion our population based data from large samples of middle aged Finnish men and women suggest that the metabolic effects of smoking are apparently increasingly overridden by the present behavioural characteristics of smokers such as high alcohol and saturated fat consumption and little exercise. The earlier generally accepted notion that smokers weigh less than non-smokers" may thus soon turn out to be anachronistic. It 
Patients, methods, and results
The study was approved by the hospital ethical committee. Three women and four men with a median age of 44 years (range 28 to 57) took part. All patients had progressive disease in more than two organ sites, which was distributed as follows: skin (seven patients), lymph nodes (three), lung (three), bone (two), and brain (one). They had all previously been treated with chemotherapy, with a median of five drugs (range four to 11), and three had also received interferon alfa. Cerebral and cutaneous metastases in one woman had previously responded to chemotherapy with the DJV3 combination (vindesine, dacarbazine, carboplatin, vinblastine, and vincristine), and another patient had had a prolonged remission with interferon alfa, as already reported.34
The planned treatment regimen was recombinant interferon gamma 100 [tg/m2 body surface area intramuscularly thrice weekly, followed by injection of recombinant tumour necrosis factor ct once weekly into the lesion at an initial dose of 5 [tg/m2 and increasing to a maximum of 150 [tg/m2 if tolerance permitted. Selected subcutaneous lesions were injected, repeatedly when possible, except in one patient who lacked a suitable lesion and was injected subcutaneously.
